Back to top

Bayer Halts Mirena Phase 3 Trial in Uterine Health: What It Means for BAYRY Investors

Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer has withdrawn a Phase 3 study called “A Multi-center, Open Label, Rand...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bayer Aktiengesellschaft (BAYRY)